EventsThe 5th International Electronic Conference on Brain Sciences & 1st International Electronic Conference on Neurosciences
Published
This submission belongs to the session S1. Neurodegenerative Diseases of the event The 5th International Electronic Conference on Brain Sciences & 1st International Electronic Conference on Neurosciences
Published date
04 Mar, 2026
Academic Editor
author-avatarGrazyna Lietzau
Citation
Sonia Di Tella, Isabella Anzuino, Paola Zinzi, Marcella Solito, Maria Rita Lo Monaco, Alice Tondinelli, Martina Petracca, Clio Scopetani Testa, Paolo Calabresi, Anna Rita Bentivoglio, Maria Caterina Silveri, Social Cognition impairments in Huntington’s Disease progression, in Proceedings of The 5th International Electronic Conference on Brain Sciences & 1st International Electronic Conference on Neurosciences, 9 March–11 March 2026, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Social Cognition impairments in Huntington’s Disease progression

Paola Zinzi 3,4
Marcella Solito 3,5
Alice Tondinelli 2
Clio Scopetani Testa 2
1. Experimental and Applied Psychology Laboratory, Department of Health and Life Sciences, Università Europea di Roma, Rome, Italy, Italy
2. Department of Psychology, Università Cattolica del Sacro Cuore, Milan, Italy, Italy
3. Movement Disorders Unit, Fondazione Policlinico Universitario ‘Agostino Gemelli’ IRCCS, Rome, Italy, Italy
4. Clinical Psychology Unit, Fondazione Policlinico Universitario ‘Agostino Gemelli’ IRCCS, Rome, Italy
5. Institute of Neurology, Università Cattolica del Sacro Cuore, Rome, Italy
6. Institute of Internal Medicine and Geriatrics, Università Cattolica del Sacro Cuore, Rome, Italy, Italy
7. Center for the Medicine of Aging, Fondazione Policlinico Universitario ‘Agostino Gemelli’ IRCCS, Rome, Italy
Abstract

Beyond its hallmark motor symptoms, Huntington’s disease (HD) involves early and progressive disruption of cognitive and psychiatric functions critical for social interaction. Theory of Mind (ToM), the ability to infer one’s own and others’ mental states, is particularly vulnerable in HD. The present study investigated cognitive and affective ToM across disease stages and their association with neuropsychiatric symptoms.

A total of 24 HD patients (12 stage I, 12 stage II) and 24 healthy controls completed the Yoni Task, assessing cognitive and affective ToM. Neuropsychiatric symptoms were evaluated using the Problem Behaviors Assessment—short version, and quality of life with the 12-item Short Form Health Survey.

Cognitive ToM was significantly impaired already in stage I HD compared to controls (mean accuracy: 68.5% vs. 87.6%, p = 0.004), while affective ToM was relatively preserved (76.4% vs. 86.2%, p = 0.095). Stage II patients showed marked deficits in both domains (cognitive ToM: 46.3%; affective ToM: 52.3%), performing significantly worse than controls (p < 0.001). Total ToM performance declined progressively across stages (p < 0.001). Lower affective ToM scores were associated with greater irritability/aggression (ρ = –0.40, p = 0.049), obsessive–compulsive symptoms (ρ = –0.51, p = 0.015), and poorer self-reported physical functioning (ρ = 0.42, p = 0.049).

ToM impairments in HD are stage-dependent, with early cognitive deficits and later involvement of affective processes. Decline in ToM performance is clinically meaningful and associated with neuropsychiatric symptoms, particularly irritability. ToM assessment may therefore provide a sensitive marker of socio-cognitive dysfunction and disease progression in HD.

Keywords
Huntington’s disease
Theory of Mind
Affective ToM
Cognitive ToM
Social Cognition
Homocysteine and homocysteine thiolactone contribute to Alzheimer's disease via TAU modifications in N2A-APPswe cells
Persea americana Seed Extract Mitigates 3-NPA-Induced Neurotoxicity in a Rat Model of Huntington’s Disease via Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Mechanisms